R&D Tax Credit Opens For Business

Great News For SMEs Down The Road

The Federal Government has confirmed that the revised start date of the R&D Tax Credit will be 1 July 2011 in a joint release from the Treasurer and the Minister for Innovation, Industry, Science and Research.

In a sweetener for SMEs, loss-making claimants will be eligible for quarterly payments of their Credit entitlements from 1 January 2014. Something to look forward to!

 The text of the press release appears below.

CROSSBENCH SUPPORT MEANS NEW R&D TAX CREDIT WILL START ON 1 JULY 2011

Australian companies will become more innovative and globally competitive thanks to the new R&D tax incentive.

The Gillard Labor Government’s $1.8 billion R&D Tax Credit will deliver more funding to innovative firms – including manufacturers, ICT and biotech – increasing productivity and Australia’s national income.

This builds on Labor’s policy reform agenda of the past four years and will be a major benefit for businesses that innovate and use R&D as a platform for future growth.

Today we welcome crossbench Senators announcing their support which means the parliamentary road-block put in place by the Coalition will finally be removed.

The new and improved Credit will target more funds to genuine R&D deserving of public support – good news for industry and better value for taxpayers.

It will deliver a 45 per cent refundable tax credit to companies with an aggregated turnover of less than $20 million and a 40 per cent non-refundable offset to all others.

This will allow more firms to benefit from our massive boost to the innovation, science and research budget, helping them grasp the opportunities of our transition to a cleaner economy.

We welcome the commitment of industry, the Greens and independent parliamentarians who have put good policy ahead of political posturing in supporting this reform. 

The development is the culmination of an extensive consultation and negotiation process.

Following discussions with the Greens, the Government will introduce quarterly payments for small and medium businesses from 1 January 2014. These firms will get their credit sooner, significantly improving their cash flow and incentive to invest in R&D.

The deferral of the start date to 1 July 2011 has an overall impact of $40m, with a negative impact of $310m in 2011-12 and a positive impact in 2012-13 of $270m.

The Government will continue to work in partnership with the business community to get the most from this landmark reform. An advisory group will be established through the Innovation Australia Board to monitor the implementation and operation of the Credit. The Government, through AusIndustry, will run an extensive education program to ensure firms are kept up to date.

MJA will keep you informed of all major developments as the Credit legislation becomes law.

Should you wish to discuss this matter any further, please do not hesitate to contact Kris Gale directly on (02) 9810 7211 or using our contact form to discuss the matters raised in this MJA Update in greater detail.

Welcome Back My Friends To The Show That Never Ends : The R&D Tax Credit

And welcome, albeit belatedly, to 2011. In our first MJA Update of the year, we will look at the comments made by Senator Carr in last Friday’s AFR (click to view) urging for the current R&D Tax Credit Bill (the Bill) to pass through the Senate unmolested in the name of fiscal consolidation. It is possible that the Bill could be presented to the Senate as early as next week.

Thar She Blows!

Senator Carr has urged that the Senate pass the Bill as the current scheme was unsustainable based on new government projections that see the cost of the program blowing out to $2.4 billion in 2012/13. Senator Carr states: “At a time when the government is looking at fiscal consolidation we are maintaining expenditure of R&D, but we can’t sustain that unless there is reform of the system for genuine research and development.”

We welcome the new focus on program cost as a driver of the reforms. It now seems that the Government’s rationale for the proposed regime does include an explicit recognition that the Credit will significantly limit R&D claims owing to the altered definitions of R&D activities and expenditures. The question remains : to achieve the Budget targets, do we need to fundamentally rewrite the eligibility criteria?

Working Without A Net

The new government projections have arrived without any available modelling to test the assumptions. So we are again working without a net but we think that the following may be safely said.

The “blow out” figure must include the 175% Incremental Concession (the Premium) which we have previously shown to be contributing about 30-35% of the cost of the current program. In opposing the definitional changes to R&D activities/expenditures, no-one has called for the retention of the Premium. Any “blow out” attributable to retaining the current definitions will have much of the wind taken from its sails once the closure of the Premium is taken into account in the projections.

We have consistently argued that closing the Premium is likely to completely pay for the higher base rates of the Credit and the introduction of foreign-owned IP claims. We welcome the release of Treasury modelling that shows that further change is necessary either to achieve revenue neutrality or even a degree of fiscal windback.

Let’s Keep It Simple

Let’s assume that the case for further cost control can be made out in the current government spending climate.

There are two simple options that would be saleable in the marketplace that would avoid all the uncertainty and angst associated with the proposed rewrites contained in the Bill:

  1. Introduce a reviewable annual claim cap at the company group level. The cap could be calculated on available claim data and could seek to limit the ability of, say, the top 25-50 claiming groups to access the Credit.
  2. Wind back the proposed rates from 10c/15c to a more modest combination of levels.

Clean and simple. Yet the Government seems unwilling to engage in any dialogue regarding either of these suggestions. This is why so many commentators are concerned that the Bill actually reflects a philosophical shift that seeks to end support for business R&D, introducing a more tightly controlled regime based around supporting business research only.

Now is the time to reignite this debate. With cost control now to the forefront of the discussion, we need to see the Treasury modelling and to explore the above cost-saving alternatives to a fundamental rewrite of the R&D definitions with all the well-documented issues and concerns.

The fact that the current Bill appears to establish a world where the Credit only supports unsuccessful commercial R&D has led many to ask whether the new program contains any real incentive effect at all. This will be the subject of our next MJA Update.

Should you wish to discuss this matter any further, please do not hesitate to contact Kris Gale directly on (02) 9810 7211 or using our contact form to discuss the matters raised in this MJA Update in greater detail.

R&D Tax Credit – Is It “Groundhog Day” All Over Again?

If you have been following the debate surrounding the re-introduction of the R&D Tax Credit (the Credit) legislation to Parliament, you’d be forgiven for feeling a little bit like Bill Murray’s character in the movie, “Groundhog Day”. You’d swear that you had already heard all this before.

And it can all get a little bit annoying for everyone having to restate their positions one more time. Just like Bill having to have the same conversation with his old buddy, Ned Ryerson, who accosts him in the street at the same place at the same time each day in the film. (You remember “Needlenose” Ned. He did the whistling belly-button trick at the high school talent show.) You might even want to follow Bill’s lead and punch the Credit right on the needlenose.

Of course, we would never advocate such an approach even if we sneakingly admired your passion. However, we do encourage you to take a deep breath, review the situation and then stay involved in the development of this critical piece of legislation for Australia’s future. With your support, we believe that the Government can hit all its policy marks without any of the radical changes contained in the legislation being necessary.

Spot the Differences

The first thing to note is there are some differences from the Bills that failed to get to the Senate in June.

The law is now attempting to be applied retrospectively from 1 July 2010. There have been two minor amendments to the Object Clause and the definition of Core R&D Activities. And there is the small matter of a minority government where passage through the Lower House is no longer a given.

Yet the Bills remain unchanged beyond that so, at the risk of going over old ground (hogs), we would like to restate the key issues as we see them. And, if like me, you have been knocking on the doors of the Independents without much result so far, it would be good to get a refresher as the Bills head towards a vote just in case you get a few minutes with one or more of the cross-benchers in your travels.

At the minute, we see everyone zeroing in on amendments to make the Bills more palatable and this is a usual political reality. It’s worth taking a step back to look at the big picture to challenge whether the sweeping changes are justified at all and whether there is another way to preserve the institutional understanding and achievements surrounding the R&D Tax Concession (the Concession).

First Cab off The Rank

The attempt to make the Bills retrospective should be dropped. Tax professionals assure us that retrospective application would be a poor move in terms of good tax practice. Further, companies need a transition into a new R&D tax regime. If it was announced immediately that the commencement date was 1 July 2011, this would allow the establishment of an independent consultation process to seek improvements in the proposed laws, followed by the pre-release of administrative guidelines so that all parties could hit the ground running in the new tax year. We support the Australian Industry Group’s call for the Board Of Taxation to head up an independent, timely consultation.

We’re Closer than You Think

Consultation, enactment and transition could easily occur in the next 8 months as there is widespread agreement on many of the main features of the Credit. There is no apparent opposition to the move from a concession to a credit format, the closure of the 175% Premium provisions and the introduction of foreign-owned IP. The disagreements all stem from the proposed changes to definitions of activities and expenditure that resulted from the Treasury consultations last year.

What’s The Headline Problem Again?

The fundamental rewrite of the definition of R&D activities and associated expenditure provisions has been justified by the Government on the basis that the program needs to remain revenue neutral going forward for the next 4 years and that only “genuine” R&D be eligible.

There are two concerns that this raises.

Firstly, the need to make these changes at all has not been supported by the release of any economic modelling by the Treasury. MJA has submitted that we believe that the cost imposts of higher base rates and foreign-owned IP will be more than offset by the closure of the incremental provisions. Given the Government has conceded that the new rules restrict the claims of existing taxpayers by 20% (with many commentators estimating a figure closer to 50-70%), it is difficult to conceive of where the required flood of new claimants will come from to leave the program costing the same. In the absence of modelling, the case for change has not been proven.

Secondly, assuming the case could be established, the Government has refused to be engaged on any alternative solutions that could deliver a revenue neutral outcome that would avoid the need to change the rules for ALL claimants, be they new or existing.

Many large corporates and their industry associations have indicated that they would be prepared to negotiate a group claim cap if they can be shown that further cost control is necessary. If the cost gap could be proved, then historical claim data would enable a reviewable group claim cap to be set to limit the amount of benefit these groups could derive each year. This would achieve the revenue neutral outcome without the need to change the current rules for the SMEs that are the Government’s priority with the Credit. And it would avoid the clear inference in the Explanatory Memorandum that large resource and manufacturing concerns do R&D that is somehow not as “genuine” as their SME brethren.

In essence, the big end of town is saying that we will accept a cap along with a lower base rate and no access to refundability if we can be shown the need for the cap based on the numbers. This would allow everyone to move on from the negative views that have been expressed about “whole of project” claims and supposed misuses of the Concession.

It seems like a sweet deal and I think the Government needs to be challenged on why it won’t discuss this offer.

Getting To the Final Reel

Politics being politics, we appreciate that the Bills may end up being the subject of passage by amendments and MJA will continue to do all it can to assist in tackling the issues of dominant purpose, feedstock expenditure and administrative power.

Today, however, we want to have a final crack at getting everyone back to the table to review whether all the myriad changes and complexities of the Bills might be avoided by a pretty straightforward negotiation and agreement.

A truly independent, focused consultation might just lead us to all want to give Ned a big hug rather than a punch on his needlenose.

Should you wish to discuss this matter any further, please do not hesitate to contact Kris Gale directly on (02) 9810 7211 or using our contact form to discuss the matters raised in this MJA Update in greater detail.

Senate Report on R&D Tax Credit Released

Report Contains a Series of Minor Recommendations Only but the Government Does Advocate Removal of Dominant Purpose Test for SMEs

The Senate Economics Legislation Committee (the Committee) released its Report into the R&D Tax Credit Bills (the Bills) yesterday. The Report sets up the debate in the Senate as to whether the Bills should become law prior to the proposed commencement date of 1 July 2010.

Overall, MJA is disappointed by the recommendations made by the Government in the Report and submits that the Dissenting Report of the Coalition Senators should be taken into account by the Senators on the cross-benches when the legislation comes to the vote.

When looked at in detail, the Government has recommended a series of minor changes to the Bill but has not undertaken any detailed analysis of most of the key concerns raised by so many of the stakeholders during the consultative process.

This is best illustrated by the Committee’s response to concerns raised regarding the proposed feedstock provisions which appeared for the first time when the Bills were read into Parliament on 13 May. At pages 61-63 of the Report, the proposed changes are outlined, followed by only one generally expressed concern made at the recent Senate hearings. The Committee goes on to note the concerns about the provisions without providing any details and then indicates that it “…does not believe this will be a problem for large companies.” It proceeds to recommend an advisory group be established to advise the administration on any “unforeseen consequences that emerge as the bill is implemented.”

Rather than dwell on whether this is a case of buck-passing of the highest order, we submit that it is a compelling example of the fact that the Committee simply didn’t have the time to absorb and analyse the feedstock issues in the same way that stakeholders were not afforded any time to undertake a similar process. Yet the new provisions stand to have a huge impact on eligible R&D for all claimants going forward. The same can be said for so many of the other concerns that have been raised regarding the Bills.

The content of the Report, spread very thinly over its 110 pages, underlines the rushed nature of the drafting process and the fact that the implications of the Bills in their current form have not been subject to anywhere near the requisite degree of scrutiny required for the making of good law.

Before setting out the recommendations and providing some further preliminary assessment of the Report, it is worth making particular note of the fact that the Government has recommended that the dominant purpose test be removed for companies with a turnover of less than $20 million. This would establish two distinct programs with separate definitions of R&D as well as levels of benefit. This takes the legislation even further away from the Government’s own announced policy, let alone the original position taken by the Cutler Report of a system that supported the same type of R&D within all organisations, large or small. It goes without saying that more compliance complexity and administrative uncertainty will follow.

We urge the Government to reconsider the passage of the Bills in the form recommended by the Committee. Policy on the run suits nobody and stakeholders have simply run out of time to consider the impact of the latest round of recommendations and amendments before the Bills need to be passed by 25 June.

The Government’s Recommendations

The Government Senators have made the following recommendations:

Recommendation 1
The Committee recommends that subsection 355-5(2) of the objects clause be
amended to clarify the reference to ‘new knowledge or information in either a
general or applied form’ by adding ‘new knowledge in an applied form  includes
new or improved materials, products, devices, processes or services’.

Recommendation 2
The Committee notes that many of the concerns were raised by organisations
who want to maintain the status quo. Nevertheless, given the concerns raised, but
acknowledging the need to ensure that public support is targeted appropriately,
the Committee recommends that the definition of ‘core R&D activities’ in section
355-25 be amended to remove the word ‘about’ from paragraph 355-25(1)(b) so
that the paragraph reads as:
[talking about experimental activities] that are conducted for the
purpose of generating new knowledge (including about the creation of
new or improved materials, products, devices, processes or services).

Recommendation 3
Given the  scope of the changes proposed, the Committee is of the view  that the
amended provisions,  including  the effect of the ‘dominant purpose’ test,  be
reviewed  after two years to ensure that the  legislation is operating consistently
with the Government’s intent.

Recommendation 4
The Committee recommends that companies with revenues under $20 million be
exempt from the dominant purpose test.   
 
Recommendation 5
The Committee recommends that a broad–based working group including small
business and union representatives be established to advise Innovation Australia
and the Department of Innovation, Industry, Science and Research about any
unforeseen circumstances  that emerge as the bill is implemented. This working
group would also inform the two year review of the bill (Recommendation 7).

Recommendation 6
The Committee notes the claim of drafting errors.  The Committee notes that
minor drafting errors are common when framing new legislation.  The
Committee does not believe that these minor errors are of sufficient magnitude to
delay passage of the bill but considers it preferable that they be dealt with before
the bill is enacted.

Recommendation 7
The Committee recommends that the Senate pass the bill, with the amendments
proposed in the earlier recommendations, before the end of June 2010. The
operation of the bill should be monitored on an ongoing basis and reviewed after
two years.

The Dissenting Report of the Coalition Senators 

The Coalition Senators have made the following recommendations:

Recommendation 1:
The Coalition recommends that the start date for these Bills be amended to 1
July 2011.

Recommendation 2:
The Coalition recommends that the passage of the Bills be delayed in order to
rectify the issue of drafting errors.

Recommendation 3:
The Coalition recommends that the definitions of core and supporting R&D be
reconsidered to be more closely aligned to the Frascati model of R&D.

Recommendation 4:
The Coalition recommends that the dominant purpose test be removed and be
reconsidered.

Recommendation 5:
The Coalition recommends that the Object clause be amended to ensure that
both research and development are given equal tax benefits.

Our Preliminary Assessment

The spectre of the 2007 Productivity Commission Report (the PC Report) looms large over the Committee’s Report. In the opening to Chapter 6, the Committee states that:

“The bill will introduce aspects of the recommendations that came out of the Productivity Commission’s 2007 review;” (page 59).

This is a stunning admission given that the PC Report was so directly contradicted by the Cutler Report and it is Cutler that the Government has repeatedly quoted as the basis of its R&D tax policy. Again, remember that the PC Report advocated the closure of the basic concession for all but the smallest companies, leaving most with an incremental option only. Cutler advocated the polar opposite – enhance the basic incentive and close the incremental option and that is exactly what the Government announced in last year’s Budget.

The Committee is in the thrall of the additionality and spillover arguments of the PC Report and repeats much of the debate that had already been resolved in the Cutler Report. From MJA’s perspective, it is clear that the Committee could not follow the arguments we put forward regarding additionality involving the need to focus support on generating additional R&D activities from the R&D projects that companies do undertake rather than designing a subsidy aimed at getting otherwise marginal projects across the line.

The Government’s recommended amendments do very little to allay the concerns expressed by so many stakeholders since the consultation process began towards the middle of last year.

The changes to the Object Clause and the definition of core R&D activities appear designed to more explicitly acknowledge the eligibility of applied R&D but do nothing to address the restrictive impacts of the dominant purpose test and the new feedstock provisions. The express inclusion of new or improved products, processes, devices, materials and services in the definition of new knowledge actually doesn’t make grammatical sense. How is it that new knowledge includes the creation of new and improved products and processes as the Committee suggests?Traditionally, new knowledge has been seen as the output of basic and applied research whilst the creation of products and processes results from experimental development ie. the application of existing knowledge. The recommendation to equate the two is very confusing.

In discussing the extent of the restrictions associated with the definitional changes, the Committee indicates that these changes are really only seeking to limit ‘business as usual’ activities and ‘whole of project’ concerns. This is giving voice to some of Treasury’s recent defences of the changes but will offer no comfort to those faced with assessments of their production-based R&D claims in the new regime.

The discussion of the concerns regarding the dominant purpose test is perfunctory and, tellingly, avoids grappling with the conclusion expressed at the Senate hearings by the current Chair of Innovation Australia’s Tax Concession Committee that determining dominant purpose under the new legislation will be entirely a matter of judgement as opposed to a question of fact. At no time is any consideration given to the power of the current ‘directly related’ definition to regulate excessive claims but the impact of the change to dominant purpose is tacitly acknowledged by the Committee’s recommendation regarding the test and SMEs.

The removal of the dominant purpose test for SMEs is, in one sense, welcome but it does establish two distinct programs by legislating two different definitions of R&D. This feels like an innovation that we could all do without as it adds yet more complexity and uncertainty, particularly for taxpayers whose turnover is in the vicinity of $20 million. What such a change does do, is reinforce the notion that the dominant purpose test is a restrictive one that will see larger companies unable to receive support for an uncertain range of R&D activities that would have otherwise qualified had the organisation simply been smaller.

Many of the major concerns raised in the recent round of consultations – beyond feedstock, these included the splitting of core and supporting R&D activities; the quality of the Explanatory Memorandum, particularly its example projects used to demonstrate the operation of the new definition of R&D; the ‘expenditure not at risk’ provisions; the greatly enhanced administrative powers; the increased complexity of the compliance regime – did not result in any specific recommendations by the Government. Like all the other parties, the fact that the timeframe for considering all the issues has been so condensed has meant that it is apparent that the Committee did not have the opportunity to actively turn its mind to many of the concerns raised.

We are very concerned that the Government accepts the Treasury’s modelling without having seen it. As we pointed out in our last Update, it appeared from the Senate hearings that Treasury’s admitted reduction of claims by 15-20% did not take into account the closure of the 175% Premium Concession which we had demonstrated previously would save 30-35% of the current cost of the program. In the absence of any published modelling, the Committee steps into the breach and offers up its own “back-of-the-envelope” calculations in support of Treasury’s estimate (page 75).

In some breathtaking assumptions, the Committee suggests that the new regime will increase current program costs by one third to one half of current levels by the combination of higher rates and new program entrants and the savings associated with the combination of the changed definition and the closure of the Premium Concession will roughly offset these costs. We wish to strenuously challenge these assumptions, particularly as they are partially based on a submission we made regarding the impact on program participation back in 1996 where the number of registrants was no more than half the current number and when participation rates fell from around 4,000 to below 3,000. It is unreasonable to assume that program uptake by new entrants will be of a similar dimension given the user base now involves roughly 8,000 Australian companies.

Of course, there is no opportunity to do this prior to the vote and the Committee appears happy with its published back-of the-envelope numbers standing in the place of any need to publish Treasury’s elusive modelling. This is not acceptable.

Finally, we remain absolutely dumbfounded by the following statement on Page 1 of the report:

 ”It is neither sustainable nor in the national interest that 60 per cent of the total government support is consumed by 100 firms out of Australia’s two million enterprises”.

You will be growing tired of us pointing out that this figure is consistent with ABS statistics on the profile of Australia’s corporate innovation activity and is in line with international practice. We have continued to emphasise throughout the consultative process that large corporates are prepared to negotiate some limits on their R&D tax benefits provided they continue to be acknowledged as performing legitimate R&D on the same basis as their smaller cousins.

However, once more, we feel compelled to point out in the strongest manner possible that the R&D tax incentive is not a finite pie, 60 per cent of which is consumed by 100 firms. Rather, it is a self-assessment program in which 60 per cent of claims are currently made by the top 100 firms. Smaller firms are not crowded out by the claims of the top 100 firms. All firms claim their entitlements against the prevailing rules. No firm’s access to the available benefit is impacted in any way by the claiming behaviour of any other company. In 25 years of consulting on the R&D Tax Concession, MJA has never met a company that does not claim or has a reduced claim because of a claim being made by another company of any size.

If this is the justification for the gutting of the incentive as the Coalition describes it, then it should be shown for the fallacy that it is. The Cutler Report called for reform to R&D taxation support for all Australia’s corporate citizens in the National Innovation System. It never intended for this reform to be the ushering in of an era where large corporates are seen as doing a lesser class of R&D when serving Australia.

What Next?

The Bills need to get through the Senate by 25 June. The Coalition appears ready to vote against the legislation so the focus now shifts to the standpoints of the Greens and the Independents.

Keep an eye out for MJA Updates in the next few days regarding the impending vote as well as any additional issues that emerge from a closer consideration of the report.

As always, should you wish to discuss this matter any further, please do not hesitate to contact Kris Gale directly on (02) 9810 7211 or using our contact form to discuss the matters raised in this MJA Update in greater detail.

R&D TAX CREDIT MAKES FRONT PAGE NEWS

Well, the front page of this MJA Update at least, which wasn’t that hard to do as it’s all that the Update is about at the moment.

In the wider media, it’s hard to get a run in these times of super profits taxes and the highest paid AFL player being someone who’s never played the game. However, the issues with the R&D Tax Credit (the Credit) remain of utmost importance, particularly with the Senate Inquiry’s report due early next week. So here we are again. We apologise for the length and current frequency of these Updates but there continues to be much to discuss and debate.

In this edition, we would like to draw your attention to some of the hot buttons in play and remind you of where we think the Credit reform process needs to go.

Bills Digest Released and it Proves to be Compelling Reading

The Department of Parliamentary Services released its Bills Digest on the Credit legislation yesterday. The Digest seeks to dispassionately summarise proceedings to date. This is not the time to pick apart some of the statements that it makes about certain matters and the overall summation it provides is a fair one.

However,the concluding comments it provides regarding the draft legislation cannot be ignored in the current context.

Specifically,

“The proposed new incentive is a significant departure from the existing incentive and could be described as an entirely new measure.” (Page 26)

“In adopting only the research elements of the Frascati definition, the proposed incentive focuses more on research and less on development. Development activities of some large entities which qualify for the existing incentive will not qualify for the proposed incentive.” (Page 26)

“The tightened definition of ‘core’ and ’supporting R&D’ will mean that some non-scientific industrial research activities will not be eligible activities.” (Page 27)

And

“Significant uncertainty still surrounds the Bill.” (Page 27)

MJA agrees with all these conclusions. We would add that the industrial research activities and the development activities of SMEs will be equally affected by the wholesale changes being made.

We also note that the Digest details the active input from manufacturing companies and associated industry associations and bodies in the recent Senate processes. This was a strong theme that unequivocally emerged at the Senate hearings, where many of those who appeared highlighted that the impact of changes would be felt across all areas of business not just the resources and infrastructure sectors.

The question for the Senate is whether it can recommend passage of the Bill in its current form. The conclusions reached in the Digest have underpinned the vast majority of public submissions that strongly oppose the proposed changes to eligibility criteria and administrative powers that have appeared in the context of hasty drafting and a questionable consultation process.

We recommend the Bills Digest as compulsory reading for all those interested in the current debate.

Additional Concerns

By dint of being a summary, the Bills Digest couldn’t cover all the live issues so we would like to briefly mention three other active concerns.

Dominant Purpose

The current Chair of the Tax Concession Committee (the TCC) of the Innovation Australia Board (the Board), Mr Peter Thomas, gave evidence in support of the introduction of the dominant purpose test with respect to relevant supporting R&D activities on the second day of the Senate hearings. The TCC is the principal decision making authority regarding eligible R&D activities. In discussing the likely application of the dominant purpose test, Mr Thomas had the following to say in suggesting that dominant purpose means the “main reason you carried it out” (i.e. the more than 50 per cent purpose),

“How do you judge whether something is a 51 per cent test or a 49 percent. In the end, it is all judgement.”

By way of contrast, the Credit’s Explanatory Memorandum (the EM) says that establishing the dominant purpose of supporting activities is a matter of the context and overall circumstances of the activities i.e. a question of fact. We wholeheartedly agree with Mr Thomas’ views and believe that they dramatically illustrate the practical difficulties of a test where administrators will be testing the veracity of a claimant’s statements about its corporate intent.

Surely this is a flawed basis for operating a self-assessment incentive and should be rejected as such.

Feedstock

Treasury maintains that the new provisions (which appeared for the first time in the Bill and were not subject to any public consultation) are a simple rewrite and consolidation of the current provisions. Again, we wish to emphasise that this is incorrect in four key respects:

  1. The notion of feedstock inputs has been extended and has been extended in an uncertain manner
  2. The provisions are to be applied to depreciating asset expenditure for the first time
  3. The point of calculation has moved from the feedstock output at the end of the financial year to an assessment of the value of the contribution of the R&D to marketable output and this may involve a series of calculations that need to be carried out over multiple years.
  4. The calculation has changed from adding a net benefit to the R&D expenditure as the expenditure is incurred to a gross calculation that inflates R&D expenditure with a separate clawback calculation when the final finished products are sold.

Yet Treasury persists with this fiction that the new rules are the same as the existing ones.

The passage of the feedstock provisions is an outstanding example of the overarching concerns with the Credit design process- there is a huge divergence of opinion about the meaning of the provisions from various stakeholders with respect to hastily drafted legislation with little or no opportunity being provided for real public consultation.

Revenue Neutrality

It has been an oft-made point in this debate that Treasury has not provided any modelling in support of its position that the overall package will be revenue neutral in outcome. Many commentators have suggested that this will not be the case and we include ourselves among them. Close examination of the Senate hearing transcript associated with Treasury’s appearance indicates that a serious flaw has emerged in Treasury’s position.

In its appearance in front of the Senate, Treasury admitted for the first time publicly that 15-20% of currently-eligible expenditure would be eliminated under the Credit and that this shortfall would be made up by new entrants, albeit with no supporting evidence as to who would comprise said entrants. What Treasury failed to acknowledge at the hearing was the saving associated with the immediate closure of the 175% Premium R&D Tax Concession. MJA has repeatedly submitted to Treasury that, on the publicly available figures,shutting down this aspect of the programwould save 30-35% of the current cost of the program. 

Treasury’s continuing failure to make any modelling available simply reinforces the widely-held view that the overall Credit package is, in fact, severely contractionary and will prove to be a massive saving to the Government in contrast to the current R&D Tax Concession.

Where Does This Leave Things?

Throughout this process, MJA has maintained that the majority of the features of the Credit should be enacted as at 1 July 2010 – the move to the credit format; the higher base rates of deduction; the introduction of foreign-owned intellectual property; and the immediate closure of the 175% Premium Tax Concession. We are still of this view. However, we cannot support the wholesale changes to the eligibility provisions and the sweeping reforms to the compliance framework and associated administrative powers and procedures in the supposed pursuit of a tightening to ensure only “genuine R&D” is supported.

Too much is at stake to stand to one side and see the cruelling of a proud program.

The Credit does not reflect announced Government policy. The Government has been let down by those who assembled the legislative package under review.

We again call for a one year delay in the implementation of changes to program definitions and administrative procedures to allow real consultation to occur and appropriate transition mechanisms to be made available prior to a 1 July 2011 commencement date.

It was very welcome to finally hear the discussion of concerns surrounding excessive claims and, indeed, rorts at the Senate hearings. Prior to that, the administration would not engage in consultation around those concerns. After all, large eligible claims were what prompted the original remarks in the Cutler report that kick started this reform process in the first place. Virtually all the key stakeholders have repeatedly submitted that they are open to negotiate a solution to the large claims that occur under the current program by the introduction of a feature such as an annual consolidated group claim cap. Iflarge claims arethe Government’s real concern, it can be dealt with in a straightforward manner. Yet Treasury will simply not engage in any meaningful discussion about various solutions. We are left to ask the simple question, ‘Why not?’

We look forward to the Senate’s reflections on that question and all the above issues in its report due next week.

We will let you know what has been said as soon as the report becomes available.

In the meantime should you wish to discuss this matter any further, please do not hesitate to contact Kris Gale directly on (02) 9810 7211 or using our contact form to discuss the matters raised in this MJA Update in greater detail.

Next Page »

About Michael Johnson Associates

Founded in 1983, Michael Johnson Associates (MJA) is Australia's leading specialist R&D tax concession firm. We work with organisations of all sizes to help them understand the benefits of a compliance approach to R&D tax concessions and grants.

We know the complex legislation, amendments and guidelines related to government programs inside out - we deal with them every day. We also write the commentary on the R&D tax incentive for the CCH Federal Tax Reporter.

Please contact us on (02) 9810 7211 or via e-mail to see how we can be of help to you.




Sign up for the MJA Update

If you'd like to receive the MJA Update email, which features regular news and views from MJA, please complete the form below and we'll send you an email approximately every three weeks.